2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 323.896 | 289.355 | 322.956 | 448.657 | 693.911 | 827.129 | 615.686 | 645.732 | 757.675 | 781.411 |
Total Income - EUR | 327.903 | 299.469 | 326.881 | 450.410 | 695.621 | 841.473 | 616.535 | 645.955 | 757.683 | 787.967 |
Total Expenses - EUR | 340.631 | 305.178 | 316.950 | 450.990 | 690.719 | 832.943 | 664.415 | 642.539 | 701.465 | 718.089 |
Gross Profit/Loss - EUR | -12.728 | -5.709 | 9.931 | -580 | 4.902 | 8.531 | -47.880 | 3.416 | 56.218 | 69.878 |
Net Profit/Loss - EUR | -12.728 | -5.709 | 7.400 | -1.989 | 3.679 | 3.988 | -47.880 | 1.651 | 46.750 | 57.299 |
Employees | 40 | 36 | 34 | 45 | 65 | 63 | 48 | 48 | 39 | 39 |
Check the financial reports for the company - Salubris Gilort S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 11.873 | 6.503 | 2.565 | 987 | 9.400 | 5.943 | 3.719 | 5.472 | 3.175 | 9.733 |
Current Assets | 83.344 | 79.968 | 90.620 | 105.627 | 123.409 | 97.046 | 73.859 | 91.958 | 104.394 | 129.399 |
Inventories | 747 | 2.169 | 1.240 | 2.301 | 2.149 | 914 | 1.351 | 657 | 2.350 | 11.634 |
Receivables | 76.403 | 71.822 | 83.743 | 100.615 | 119.748 | 83.460 | 64.798 | 91.244 | 78.404 | 94.909 |
Cash | 6.195 | 5.976 | 5.637 | 2.712 | 1.513 | 12.672 | 7.709 | 56 | 23.640 | 22.855 |
Shareholders Funds | 17.427 | 11.863 | 19.142 | 16.830 | 20.200 | 23.797 | -24.534 | -22.339 | 24.342 | 81.586 |
Social Capital | 20.080 | 20.247 | 20.041 | 19.702 | 19.340 | 18.966 | 18.606 | 18.194 | 18.250 | 18.195 |
Debts | 77.791 | 74.608 | 74.042 | 89.785 | 112.609 | 79.191 | 102.112 | 119.770 | 83.228 | 57.545 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "3811 - 3811" | |||||||||
CAEN Financial Year |
3811
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Salubris Gilort S.r.l.